ReadMyRhythm vs Geriatric screening Tool

Using cloud-based technology, Read My Rhythm gives consumers immediate access to a physician for ECG interpretation through their phone. Capture your recording. Upload to Read My Rhythm. Get the insight you need on your heart arrhythmia now. It's that simple. Highlights : - All ECGs are stored in a secure HIPAA-compliant manner that can be shared with your physician at any time. - Read My Rhythm was created by professional cardiologists, ensuring accurate interpretations every time! - In addition to an interpretation, patients will receive a general explanation with follow-up guidance for their ECG recording. Terms of Use: https://rmr.readmyrhythm.com/terms-of-use Privacy Policy: https://rmr.readmyrhythm.com/privacy-policy ReadMyRhythm offers auto-renewable subscriptions: • Monthly Subscription: $9.99/month (15 ECG readings per month) • Yearly Subscription: $99.99/year (15 ECG readings per month, billed annually) • Flex Plan: $1.99 per individual ECG reading Subscriptions automatically renew unless cancelled at least 24 hours before the current period ends. Manage subscriptions in App Store Account Settings.

This app is a specialized assessment tool for older patients with cancer, developed by the Korean Cancer Study Group (KCSG) and Seoul National University Bundang Hospital for clinicians and nurses. It provides systematic support for complex treatment decisions in geriatric oncology, based on objective data. Three tools are available in this single app. [Main Tools (3)] Severe Toxicity Prediction Precisely predicts the risk of Grade 3 or higher severe chemotherapy side effects based on patient data. It helps in recognizing risks in advance during treatment planning. KCSG-Geriatric Score (KG-7 Score) As a screening assessment tool composed of 7 core questions, it quickly screens for patients who require a full geriatric assessment. It is utilized as a standard for objectively understanding the patient's current condition. Prognosis Index Predicts the patient's life expectancy through a multidimensional geriatric assessment. It provides a key evidence base for setting realistic treatment goals and for counseling with patients and their families. Each tool can be used independently, and its results will provide objective data for treatment decision-making in geriatric oncology. Experience optimal decision-making based on objective data.